1607 Capital Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
SCM
RCM
PCM
1607 Capital Partners's BMEZ Position: Q2 2026 in Review
1607 Capital Partners reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 14% in Q2 2026, selling an estimated $1.04M and leaving 442,213 shares worth $6.79M. The position accounts for 0.59% of the portfolio, ranked #46.
1607 Capital Partners first reported a position in BMEZ in Q1 2021 and has held it in 19 quarters since. The position peaked at $26.3M in Q1 2023. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.
- 1607 Capital Partners held 442,213 shares of BlackRock Health Sciences Trust II worth $6.79M as of Q2 2026.
- 1607 Capital Partners sold 72,260 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $1.04M.
- BlackRock Health Sciences Trust II made up 0.59% of 1607 Capital Partners's portfolio in Q2 2026, its #46 holding.
- 1607 Capital Partners first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and has held it in 19 quarters since.
- 1607 Capital Partners's BlackRock Health Sciences Trust II position peaked at $26.3M in Q1 2023.
- 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.
Based on 1607 Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.